Unique Domain for a Unique Target: Selective Inhibitors of Host Cell DDX3X to Fight Emerging Viruses
- 30 July 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (17), 9876-9887
- https://doi.org/10.1021/acs.jmedchem.0c01039
Abstract
Emerging viruses like Dengue, West Nile, Chikungunya and Zika can cause widespread viral epidemics. Developing novel drugs or vaccines against specific targets for each virus is a difficult task. As obligate parasites, all viruses exploit common cellular pathways opening the possibility to develop broad-spectrum antiviral agents targeting host factors. The human DEAD-box RNA helicase DDX3X is an essential cofactor for viral replication but dispensable for cell via-bility. Herein, we exploited the presence of a unique structural motif of DDX3X not shared by other cellular enzymes to develop a theoretical model to aid in the design of a novel class of highly selective inhibitors acting against such specific target, thus limiting off-targeting effects. High throughput virtual screening led us to identify hit compound 5, endowed of promising anti-enzymatic activity. To improve its aqueous solubility, 5 and its two enantiomers were synthesized and converted into their corresponding acetate salts (compounds 11, 12 and 13) . In vitro mutagenesis and biochemical and cellular assays further confirmed that the developed molecules were selective for DDX3X and were able to suppress replication of West Nile and Dengue viruses in infected cells in micromolar range while showing no toxicity for uninfected cells. These results provide proof-of-principle for a novel strategy in developing highly selec-tive and broad-spectrum antiviral molecules active against emerging and dangerous viral pathogens. This study paves the way for the development of larger focused libraries targeting such domain, in order to expand SAR studies and fully characterize their mode of interaction.Keywords
Funding Information
- Consiglio Nazionale delle Ricerche
This publication has 38 references indexed in Scilit:
- The DEAD-box helicase DDX3 substitutes for the cap-binding protein eIF4E to promote compartmentalized translation initiation of the HIV-1 genomic RNANucleic Acids Research, 2013
- The virocell concept and environmental microbiologyThe ISME Journal, 2012
- A Motif Unique to the Human Dead-Box Protein DDX3 Is Important for Nucleic Acid Binding, ATP Hydrolysis, RNA/DNA Unwinding and HIV-1 ReplicationPLOS ONE, 2011
- Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesisProceedings of the National Academy of Sciences of the United States of America, 2011
- Comparative Structural Analysis of Human DEAD-Box RNA HelicasesPLOS ONE, 2010
- A broad-spectrum antiviral targeting entry of enveloped virusesProceedings of the National Academy of Sciences of the United States of America, 2010
- Exploiting the promiscuity of imatinibJournal of Biology, 2009
- An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocolBMC Biotechnology, 2008
- Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKɛ-mediated IRF activationThe EMBO Journal, 2008
- UCSF Chimera?A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004